Pfizer signs up for longer pact with Icon, pens extra 2-year clause

Back in 2016, Pfizer signed up with CRO Icon to help it, alongside other CROs PPD and Parexel, run its vast trial network.

Clearly happy with its partner, Pfizer has now penned an extension to that deal, adding three more years with a clause that could also see an extra two years on top of that.